Everett Harris & Co. CA Sells 875 Shares of Danaher Co. (NYSE:DHR)

Everett Harris & Co. CA lessened its holdings in Danaher Co. (NYSE:DHR) by 6.8% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,075 shares of the conglomerate’s stock after selling 875 shares during the quarter. Everett Harris & Co. CA’s holdings in Danaher were worth $1,726,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of DHR. MBM Wealth Consultants LLC grew its position in shares of Danaher by 2.0% during the 2nd quarter. MBM Wealth Consultants LLC now owns 3,701 shares of the conglomerate’s stock worth $529,000 after buying an additional 74 shares during the period. Mechanics Bank Trust Department grew its position in Danaher by 1.7% in the 2nd quarter. Mechanics Bank Trust Department now owns 4,384 shares of the conglomerate’s stock valued at $627,000 after purchasing an additional 75 shares during the period. Adirondack Trust Co. grew its position in Danaher by 3.1% in the 1st quarter. Adirondack Trust Co. now owns 2,635 shares of the conglomerate’s stock valued at $349,000 after purchasing an additional 78 shares during the period. Cornerstone Advisors Inc. grew its position in Danaher by 2.9% in the 1st quarter. Cornerstone Advisors Inc. now owns 2,783 shares of the conglomerate’s stock valued at $367,000 after purchasing an additional 79 shares during the period. Finally, Copperwynd Financial LLC grew its position in Danaher by 1.9% in the 2nd quarter. Copperwynd Financial LLC now owns 4,144 shares of the conglomerate’s stock valued at $592,000 after purchasing an additional 79 shares during the period. Institutional investors and hedge funds own 78.52% of the company’s stock.

In other Danaher news, Chairman Mitchell P. Rales bought 2,500 shares of the stock in a transaction dated Friday, August 23rd. The shares were bought at an average cost of $139.52 per share, for a total transaction of $348,800.00. Following the purchase, the chairman now directly owns 3,030,453 shares of the company’s stock, valued at approximately $422,808,802.56. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Also, SVP Angela S. Lalor sold 20,000 shares of Danaher stock in a transaction on Tuesday, July 23rd. The stock was sold at an average price of $142.30, for a total value of $2,846,000.00. Following the sale, the senior vice president now owns 58,515 shares in the company, valued at $8,326,684.50. The disclosure for this sale can be found here. Insiders have sold a total of 177,202 shares of company stock worth $25,175,829 over the last ninety days. Insiders own 11.40% of the company’s stock.

Several analysts recently issued reports on the stock. Needham & Company LLC reissued a “buy” rating and issued a $155.00 price target (up previously from $142.00) on shares of Danaher in a research report on Friday, July 19th. Robert W. Baird lifted their price target on shares of Danaher from $131.00 to $148.00 and gave the company an “outperform” rating in a research report on Friday, July 19th. Piper Jaffray Companies lifted their price target on shares of Danaher from $148.00 to $153.00 and gave the company a “neutral” rating in a research report on Thursday, July 18th. Wolfe Research assumed coverage on shares of Danaher in a research report on Thursday, May 30th. They issued an “outperform” rating for the company. Finally, Royal Bank of Canada set a $134.00 price target on shares of Danaher and gave the company a “hold” rating in a research report on Friday, July 19th. Three investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus price target of $143.54.

DHR opened at $141.77 on Thursday. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.32 and a quick ratio of 1.91. The company has a market capitalization of $99.97 billion, a price-to-earnings ratio of 31.37, a P/E/G ratio of 2.52 and a beta of 0.94. The firm’s fifty day moving average price is $140.18 and its two-hundred day moving average price is $135.10. Danaher Co. has a 1 year low of $94.59 and a 1 year high of $145.50.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Thursday, July 18th. The conglomerate reported $1.19 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.15 by $0.04. The firm had revenue of $5.16 billion for the quarter, compared to the consensus estimate of $5.09 billion. Danaher had a net margin of 12.22% and a return on equity of 11.53%. The business’s revenue for the quarter was up 3.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.15 EPS. As a group, equities analysts anticipate that Danaher Co. will post 4.79 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Friday, September 27th will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.48%. The ex-dividend date is Thursday, September 26th. Danaher’s dividend payout ratio is 15.04%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Read More: Understanding Market Liquidity

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply